Anaemia is a common extra-articular manifestation of rheumatoid arthritis. It is often mild to moderate in severity, is normochromic and normocytic, and correlates with disease activity. Investigation of the cause may be made by the measurement of biochemical indices of iron status in samples of peripheral blood.
These parameters are confused in rheumatoid arthritis, however, because the acute phase response alters indices relating to anaemia. Blood loss from the gastrointestinal tract is often suspected in rheumatoid arthritis. This may be caused by drugs or the disease process, but findings in the upper gastrointestinal tract do not always explain the anaemia. The investigation of anaemia in such a confused setting requires a logical approach if the anaemia of iron deficiency is to be differentiated from other causes, particularly that caused by a chronic inflammatory disease.
In a group of 28 patients with rheumatoid arthritis, all of whom were anaemic, we determined the bone marrow iron status for subsequent comparison with measurements of red cell and biochemical parameters of the peripheral blood. On the basis that iron absorption by the gastrointestinal tract is normally inversely proportional to body iron stores, a low dose iron absorption test was performed.2 3 In addition, an upper gastrointestinal endoscopic examination was performed in those patients found to have an iron deficient bone marrow. This study examines the clinical usefulness of these methods of assessing iron status in patients with rheumatoid arthritis using bone marrow iron as the standard test for iron deficiency.
Patients and methods

PATIENTS
Twenty eight patients with definite or classical rheumatoid arthritis were investigated. Patients were considered for the study when their haemoglobin concentration was 90 g/l or less, or when there was a decrease in the haemoglobin content of 10 g/l per month without obvious cause. Patients were excluded if they had received iron treatment within one month, had a macrocytosis due to treatment with cytotoxic drugs, or had a disease that may have contributed to the anaemia, although one patient with clinically inactive ulcerative colitis was included in the study. All The activity of the rheumatoid disease was assessed using a visual analogue scale for early morning stiffness and joint pain, the Ritchie index, a health assessment questionnaire score, platelet count, and plasma viscosity. A 20% change in the same direction in two or more parameters was taken to indicate a change in disease activity over the three month follow up period. All parameters were measured by one observer (AD).
STATISTICAL METHODS
Significance was assessed using Student's t test for parametric data, the Mann-Whitney U test for non-parametric data, and the product moment correlation coefficient between indices.
Results
Of the 28 patients studied, 14 patients had iron present in the bone marrow and 14 patients were iron deficient. The two groups were similar with respect to age, sex, presence of rheumatoid factor, and disease duration. patient's disease activity status was unknown at three months.
Discussion
The significance and differentiation between the anaemia of chronic disease and iron deficiency anaemia in patients with rheumatoid arthritis has recently been reviewed. 3 The anaemia of chronic disease states correlates with the progression of bony erosions4 and its early presence is associated with a poor prognosis.5 6 In the long term, deaths related to rheumatoid disease are more common in patients who are anaemic at the time ofdiagnosis. 
